Low dose of isotretinoin: a comprehensive review

A Abdelmaksoud, T Lotti, R Anadolu… - Dermatologic …, 2020 - Wiley Online Library
Isotretinoin is a first‐generation retinoid initially approved for the treatment of severe cases
of acne vulgaris (nodulocystic acne). Because of its broad anti‐inflammatory and …

Molecular targets for proliferative vitreoretinopathy

F Wu, D Eliott - Seminars in ophthalmology, 2021 - Taylor & Francis
While innovations in the surgical management of retinal detachment (RD) with proliferative
vitreoretinopathy (PVR) have significantly improved anatomic and visual outcomes over the …

TRActional DIabetic reTInal detachment surgery with co-adjuvant intravitreal dexamethasONe implant: the TRADITION STUDY

M Iglicki, D Zur, A Fung, PH Gabrielle, M Lupidi… - Acta Diabetologica, 2019 - Springer
Aim Main failure of diabetic tractional retinal detachment (TRD) surgery is the development
of proliferative vitreoretinopathy (PVR), causing higher re-detachment rates. We investigated …

[HTML][HTML] Proliferative vitreoretinopathy: an update on the current and emerging treatment options

L Ferro Desideri, D Artemiev, S Zandi… - Graefe's Archive for …, 2024 - Springer
Proliferative vitreoretinopathy (PVR) remains the main cause of failure in retinal detachment
(RD) surgery and a demanding challenge for vitreoretinal surgeons. Despite the large …

[HTML][HTML] Steroid drugs as an Adjunct for reducing the incidence of proliferative vitreoretinopathy after Rhegmatogenous Retinal detachment surgery: a Meta-analysis of …

M Xu, X Fan, X Huang, X Chen, Y Shao, X Li - Ophthalmic Research, 2023 - karger.com
Introduction: The efficacy and influence of steroids for reducing the incidence of proliferative
vitreoretinopathy (PVR) after rhegmatogenous retinal detachment (RRD) surgery remain …

[HTML][HTML] Combined 5-fluorouracil and low molecular weight heparin for the prevention of postoperative proliferative vitreoretinopathy in patients with retinal …

C Chen, P Chen, X Liu, H Li - Frontiers in Medicine, 2021 - frontiersin.org
Background: Postoperative proliferative vitreoretinopathy (PVR) remains a dilemma for
retinal surgeons. We performed a literature search and meta-analyses to figure out whether …

Translational and clinical advancements in management of proliferative vitreoretinopathy

A Shahlaee, CF Woeller, NJ Philp… - Current opinion in …, 2022 - journals.lww.com
Although multiple molecular targets have been investigated to prevent and treat PVR, none
have yet demonstrated substantial evidence of clinical benefit in humans though some show …

[HTML][HTML] Salinomycin inhibits proliferative vitreoretinopathy formation in a mouse model

AM Heffer, V Wang, RT Libby, SE Feldon, CF Woeller… - PloS one, 2020 - journals.plos.org
Proliferative vitreoretinopathy (PVR) is a progressive disease that develops in a subset of
patients who undergo surgery for retinal detachment repair, and results in significant vision …

Clinical therapeutics for proliferative vitreoretinopathy in retinal detachment

F Sabatino, P Banerjee, MMK Muqit - Survey of Ophthalmology, 2024 - Elsevier
Proliferative vitreoretinopathy (PVR) is an abnormal and prolonged healing response to
retinal injury (retinal detachment, post-retinal detachment surgery) characterised by …

Proliferative vitreoretinopathy prophylaxis: mission (im) possible

F Schaub, AM Abdullatif, S Fauser - Der Ophthalmologe, 2021 - Springer
Zusammenfassung Hintergrund Die proliferative Vitreoretinopathie (PVR) ist eine der
bedeutendsten Komplikationen nach vitreoretinaler Chirurgie. Chirurgische Strategien sind …